BFC Planning’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
Other funds holding BCRX
JHC
BFC Planning's BCRX Position: Q3 2026 in Review
BFC Planning opened a new position in BioCryst Pharmaceuticals (BCRX) in Q3 2026: 77 shares worth $641. The stake represents ﹤0.01% of the portfolio and ranks #3253 among its holdings.
241 funds tracked by Wall St. Rank hold BCRX as of Q3 2026.
- BFC Planning held 77 shares of BioCryst Pharmaceuticals worth $641 as of Q3 2026.
- BioCryst Pharmaceuticals was a new BFC Planning position in Q3 2026.
- BioCryst Pharmaceuticals made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #3253 holding.
- 241 funds tracked by Wall St. Rank held BioCryst Pharmaceuticals as of Q3 2026.
Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.